Clinical Trial Update: Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of DaxibotulinumtoxinA (DAXI) for injectable treatment of forehead lines (frontalis) has completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Forehead Lines
• Frown Lines
• Non-specific Aesthetic Facial Lines

Drugs mentioned

• DaxibotulinumtoxinA (DAXI) (daxibotulinumtoxinA)

Snippet

Sponsor: Revance Therapeutics, Inc. | Conditions: Frown Lines | Phase 2 | Status: COMPLETED | Results posted: 2023-02-16